Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

6 Sept 2021

Abstract excerpt

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive cancer with a high rate of death globally. The use of bioinformatics may help to identify immune cell-related genes both as targets for potential immunotherapies and for their value associated with predicting therapy responses. METHODS: In this study, mRNA expression profiles of HCC samples from The Cancer Genome Atlas (TCGA) database were subjected to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34488768
DOI: 10.1186/s12935-021-02183-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinomaPMID 34488768Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular CarcinomaSemantic proximity Read ↗

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationSemantic proximity Read ↗

Identification and Validation of Tumour Microenvironment-Based Immune Related Signature for Hepatocellular Carcioma: Immunotherapeutic ImplicationsSemantic proximity Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Development of an immune-related prognostic index associated with hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma.Semantic proximity Read ↗

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinomaSemantic proximity Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

Integrative Characterization of Immune-relevant Genes in Hepatocellular CarcinomaSemantic proximity Read ↗

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.